• J Pain · Apr 2016

    (435) Nausea and vomiting with oliceridine (TRV130), a novel μ receptor G protein Pathway Selective modulator (μ-GPS), vs morphine: an analysis of tolerability from a phase 2b randomized clinical trial.

    • H Minkowitz, N Singla, D Soergel, D Burt, and F Skobieranda.
    • Lotus Clinical Research, Pasadena, CA.
    • J Pain. 2016 Apr 1; 17 (4S): S83.

    no abstract available

      Pubmed     Copy Citation  

      Add institutional full text...

    Notes

    hide…